AKTIENANLEIHE - PFIZER INC Share Price

Certificat

DE000VD2W696

Market Closed - Bid/Ask 01:16:18 23/05/2024 pm IST After market 01:12:25 am
102.4 EUR +1.99% Intraday chart for AKTIENANLEIHE - PFIZER INC 100.5 -1.82%
1 month+5.91%
Date Price Change
23/24/23 102.4 +1.99%
22/24/22 100.4 +0.22%
21/24/21 100.1 -0.52%
20/24/20 100.6 -0.57%
17/24/17 101.2 +0.19%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 01:16 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD2W69
ISINDE000VD2W696
Date issued 27/03/2024
Strike 34.15 $
Maturity 27/03/2025 (308 Days)
Parity 0.03 : 1
Emission price 100
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 102.4
Lowest since issue 92.78
Spread 1
Spread %0.10%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6 USD
Average target price
31.94 USD
Spread / Average Target
+7.90%
Consensus